| James Vincent Raccuia, MD | |
|
1200 E Michigan Ave Ste 655, Lansing, MI 48912-1837 | |
| (517) 267-2460 | |
| Not Available |
| Full Name | James Vincent Raccuia |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 8 Years |
| Location | 1200 E Michigan Ave Ste 655, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194175398 | NPI | - | NPPES |
| 5315077017 | Other | MI | CONTROLLED SUBSTANCE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 4301110299 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blanchard Valley Hospital | Findlay, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Specialty Physicians Of Blanchard Valley Llc | 2668547613 | 102 |
News Archive
At the height of the COVID-19 pandemic in April, a 14-year-old boy was admitted to the emergency department at Nemours Children's Health System in Delaware with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the U.S.
A pain-killing medication appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests.
A study by the New Dynamics of Ageing Programme, a joint initiative by Research Council's UK (RCUK), examines the relationship between successful ageing and mobility patterns.
QRxPharma Limited announced today that the United States Patent and Trademark Office issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery.
› Verified 2 days ago
| Entity Name | Specialty Physicians Of Blanchard Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689835415 PECOS PAC ID: 2668547613 Enrollment ID: O20080826000542 |
News Archive
At the height of the COVID-19 pandemic in April, a 14-year-old boy was admitted to the emergency department at Nemours Children's Health System in Delaware with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the U.S.
A pain-killing medication appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests.
A study by the New Dynamics of Ageing Programme, a joint initiative by Research Council's UK (RCUK), examines the relationship between successful ageing and mobility patterns.
QRxPharma Limited announced today that the United States Patent and Trademark Office issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Vincent Raccuia, MD 1200 E Michigan Ave Ste 655, Lansing, MI 48912-1837 Ph: (517) 267-2460 | James Vincent Raccuia, MD 1200 E Michigan Ave Ste 655, Lansing, MI 48912-1837 Ph: (517) 267-2460 |
News Archive
At the height of the COVID-19 pandemic in April, a 14-year-old boy was admitted to the emergency department at Nemours Children's Health System in Delaware with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the U.S.
A pain-killing medication appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests.
A study by the New Dynamics of Ageing Programme, a joint initiative by Research Council's UK (RCUK), examines the relationship between successful ageing and mobility patterns.
QRxPharma Limited announced today that the United States Patent and Trademark Office issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery.
› Verified 2 days ago
Dr. Paul David Schneider, M.D. Surgery Medicare: Medicare Enrolled Practice Location: Sparrow Hospital - Trauma Services, 1215 E. Michigan Ave, Lansing, MI 48912 Phone: 517-267-2460 Fax: 517-267-2462 | |
Debra Marie Pierce, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 E Michigan Ave, Suite 655, Lansing, MI 48912 Phone: 517-267-2460 | |
Dr. Nadim El-hage, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-5902 | |
Jordyn Atwater, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 E Michigan Ave Ste 655, Lansing, MI 48912 Phone: 517-364-5902 | |
Dr. Kurt M Carter, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 405 W Greenlawn Ave, Ste 305, Lansing, MI 48910 Phone: 517-483-4795 Fax: 517-483-4862 | |
Ms. Suzanne Marie Hanses, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 4911 W St Joe Hwy, Ste 102, Lansing, MI 48917 Phone: 517-853-3600 Fax: 517-853-0085 |